Interoperability in eHealth Systems
... But unless the term is associated with a unique code from a code system, automated processing of the exchanged term is very difficult because an application, programmed to use “heart attack”, would not understand “myocardial infarction” When a term from medical terminology system is used such as SNO ...
... But unless the term is associated with a unique code from a code system, automated processing of the exchanged term is very difficult because an application, programmed to use “heart attack”, would not understand “myocardial infarction” When a term from medical terminology system is used such as SNO ...
Standards for Accreditation of Dental Sleep Medicine Facilities
... [AGD PACE]) provided by a dental sleep medicine focused non-profit organization or accredited dental school. Compliance with CE requirements is required for all dental directors, regardless of whether they are certified by the ABDSM. Compliance with this standard must be documented. Standards B-5 th ...
... [AGD PACE]) provided by a dental sleep medicine focused non-profit organization or accredited dental school. Compliance with CE requirements is required for all dental directors, regardless of whether they are certified by the ABDSM. Compliance with this standard must be documented. Standards B-5 th ...
Age and Risks of FDA–Approved Long-Acting  -Adrenergic Receptor Agonists 2
... basis for a broad analysis of the safety of LABAs. Submitted data were prespecified regarding trial inclusion criteria, comparison groups, end points, subgroups, and statistical methods. Additional analyses for this article that focused on pediatric populations were conducted for a better understandi ...
... basis for a broad analysis of the safety of LABAs. Submitted data were prespecified regarding trial inclusion criteria, comparison groups, end points, subgroups, and statistical methods. Additional analyses for this article that focused on pediatric populations were conducted for a better understandi ...
Rx Only For external use only. Not for ophthalmic use.
... Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity (See PRECAUTIONS – Pediatric Use) If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted. Iodochlorhydroxyquin may be abso ...
... Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity (See PRECAUTIONS – Pediatric Use) If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted. Iodochlorhydroxyquin may be abso ...
Protein-Losing Enteropathy after the Fontan Operation: Clinical
... Although PLE in patients with congenital heart disease who have had a Fontan operation is lifethreatening, no long-term effective therapy for this condition has been developed. Initial treatment modalities for PLE include a low fat, high protein, medium-chain triglyceride diet to reduce intestinal l ...
... Although PLE in patients with congenital heart disease who have had a Fontan operation is lifethreatening, no long-term effective therapy for this condition has been developed. Initial treatment modalities for PLE include a low fat, high protein, medium-chain triglyceride diet to reduce intestinal l ...
TL5-B - Prentice Move phases and evaluation
... patient care workstation area and will be picked up there at the beginning of the shift. ...
... patient care workstation area and will be picked up there at the beginning of the shift. ...
Costing statement: Ulcerative colitis
... The drug costs for the TNF-alpha inhibitor biologic drugs are based on the calculations used for the costing statement on TA329 Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy. Please refer to that document ...
... The drug costs for the TNF-alpha inhibitor biologic drugs are based on the calculations used for the costing statement on TA329 Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy. Please refer to that document ...
Evidence-based pharmacotherapy of Generalized Anxiety Disorder
... scale was significantly greater for both paroxetinetreatment groups, indicating a significant improvement in quality of life. The third randomized controlled trial was an 8-wk, flexible-dose study conducted in 326 US patients with GAD. Paroxetine (20–50 mg/d) was significantly superior to placebo (p<0.0 ...
... scale was significantly greater for both paroxetinetreatment groups, indicating a significant improvement in quality of life. The third randomized controlled trial was an 8-wk, flexible-dose study conducted in 326 US patients with GAD. Paroxetine (20–50 mg/d) was significantly superior to placebo (p<0.0 ...
Quality and Accountability in Health Care Delivery
... of poor governance and administrative accountability in the delivery of primary health care services through the public sector (Banerjee, Deaton, and Duflo 2004; Banerjee, Duflo, and Glennerster 2008), market-based provision of health care may present a legitimate alternative in spite of its many t ...
... of poor governance and administrative accountability in the delivery of primary health care services through the public sector (Banerjee, Deaton, and Duflo 2004; Banerjee, Duflo, and Glennerster 2008), market-based provision of health care may present a legitimate alternative in spite of its many t ...
ARVO 2016 Annual Meeting Abstracts 282 Macular diseases
... ARVO 2016 Annual Meeting Abstracts disease, and also for the antimalarial prevention. The incidence of the maculopathy is about 1% to 5 years. The main risk factor is the cumulative dose. The daily overdose has also been involved. Some risk factor are conventionally referred, including: age over 60 ...
... ARVO 2016 Annual Meeting Abstracts disease, and also for the antimalarial prevention. The incidence of the maculopathy is about 1% to 5 years. The main risk factor is the cumulative dose. The daily overdose has also been involved. Some risk factor are conventionally referred, including: age over 60 ...
General Guidance for the Administration of Vaccines
... They must all do so as named individuals on the PGD. Drawing up PGDs Trusts will identify a designated team of people including a senior doctor, senior pharmacist and a senior nurse who will take responsibility for PGD development in their area. In this Trust, the Medicines Management Committee rati ...
... They must all do so as named individuals on the PGD. Drawing up PGDs Trusts will identify a designated team of people including a senior doctor, senior pharmacist and a senior nurse who will take responsibility for PGD development in their area. In this Trust, the Medicines Management Committee rati ...
ethics - Il Progetto Invecchiamento
... delirium requires Rx of primary disease, avoiding complications, managing behavioral problems, providing rehabilitation ...
... delirium requires Rx of primary disease, avoiding complications, managing behavioral problems, providing rehabilitation ...
Official Journal of The Kidney Cancer Association
... of this issue represent more than just branches of what a consortium calls “phylogenetic trees for RCC.” These spoke-like directions might be a metaphor for investigations into the biology of the disease itself, branching out into myriad avenues as we seek to define and redefine biomarkers and gain ...
... of this issue represent more than just branches of what a consortium calls “phylogenetic trees for RCC.” These spoke-like directions might be a metaphor for investigations into the biology of the disease itself, branching out into myriad avenues as we seek to define and redefine biomarkers and gain ...
gingival enlargement
... • CO2 or argon-laser surgery has been proposed as surgical treatment of gingival overgrowth because of decreased surgical time and rapid post-operative haemostasis. ...
... • CO2 or argon-laser surgery has been proposed as surgical treatment of gingival overgrowth because of decreased surgical time and rapid post-operative haemostasis. ...
of lens opacities in a randomised placebo controlled study
... symptoms volunteered (for example, visual deterioration) by the patient were also recorded. Compliance with study treatment (defined as >90% of scheduled treatment taken) was checked by questioning and by reviewing the number of tablets remaining. All hospital admissions (including those for catarac ...
... symptoms volunteered (for example, visual deterioration) by the patient were also recorded. Compliance with study treatment (defined as >90% of scheduled treatment taken) was checked by questioning and by reviewing the number of tablets remaining. All hospital admissions (including those for catarac ...
1 - GHDonline
... Approximately 30% of the world’s population receives 74% of the world’s surgical procedures, with the poorest third obtaining a meager 3% [2]. Though limited data exist, it is likely that the mortality and morbidity rates from surgical complications are higher among the global poor [4][5]. Two billi ...
... Approximately 30% of the world’s population receives 74% of the world’s surgical procedures, with the poorest third obtaining a meager 3% [2]. Though limited data exist, it is likely that the mortality and morbidity rates from surgical complications are higher among the global poor [4][5]. Two billi ...
Review article
... incurable condition that frequently requires the use of potent drugs to control symptoms. Glucocorticoids are still the most effective remission-inducing medication but, for patients who fail to respond and for those who develop side-effects or require long-term glucocorticoid treatment, immunomodul ...
... incurable condition that frequently requires the use of potent drugs to control symptoms. Glucocorticoids are still the most effective remission-inducing medication but, for patients who fail to respond and for those who develop side-effects or require long-term glucocorticoid treatment, immunomodul ...
MIGS extending beyond glaucoma
... costs and report consistent earnings. So while a few people had been recognized and rewarded for innovation, many others had been laid off. As a result, the strongest and most consistent message . . . was that people in the company, at all levels, were risk-averse. Like the mice in the lab experimen ...
... costs and report consistent earnings. So while a few people had been recognized and rewarded for innovation, many others had been laid off. As a result, the strongest and most consistent message . . . was that people in the company, at all levels, were risk-averse. Like the mice in the lab experimen ...
Guideline for the Management of Adult Patients with a High Output
... A high output stoma is defined as one which produces more than 2000ml/day (for more than 3 days), or one in which the volume has not been measured accurately or is producing less than 2000ml daily but there is ongoing issues with fluid and electrolyte balance. ...
... A high output stoma is defined as one which produces more than 2000ml/day (for more than 3 days), or one in which the volume has not been measured accurately or is producing less than 2000ml daily but there is ongoing issues with fluid and electrolyte balance. ...
Port-a-cath Package Oct 28 2013
... catheter connects the port to a vein. Under the skin, the port has a septum through which drugs can be injected and blood samples can be drawn many times, usually with less discomfort for the patient than a more typical “needle stick”. Ports are used mostly to treat hematology and oncology patients, ...
... catheter connects the port to a vein. Under the skin, the port has a septum through which drugs can be injected and blood samples can be drawn many times, usually with less discomfort for the patient than a more typical “needle stick”. Ports are used mostly to treat hematology and oncology patients, ...
nrg oncology rtog 0522 a randomized phase iii trial
... fractionation with split-course (AFX-S), and accelerated fractionation by concomitant boost (AFXCB) in the management of patients with stage III-IV HNSCC. Between September 1991 and August 1997, 1113 patients were enrolled. Analysis undertaken in September of 1999 revealed that AFX-CB (p=0.050) and ...
... fractionation with split-course (AFX-S), and accelerated fractionation by concomitant boost (AFXCB) in the management of patients with stage III-IV HNSCC. Between September 1991 and August 1997, 1113 patients were enrolled. Analysis undertaken in September of 1999 revealed that AFX-CB (p=0.050) and ...